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Cryptococcus neoformans is pathogenic yeast, responsible for highly lethal infections
in compromised patients around the globe. C. neoformans typically initiates infections
in mammalian lung tissue and subsequently disseminates to the central nervous
system where it causes significant pathologies. Virulence genes of C. neoformans are
being characterized at an increasing rate, however, we are far from a comprehensive
understanding of their roles and genetic interactions. Some of these reported virulence
genes are scattered throughout different databases, while others are not yet included.
This study gathered and analyzed 150 reported virulence associated factors (VAFs) of
C. neoformans. Using the web resource STRING database, our study identified different
interactions between the total VAFs and those involved specifically in lung and brain
infections and identified a new strain specific virulence gene, SHO1, involved in the
mitogen-activated protein kinase signaling pathway. As predicted by our analysis, SHO1
expression enhanced C. neoformans virulence in a mouse model of pulmonary infection,
contributing to enhanced non-protective immune Th2 bias and progressively enhancing
fungal growth in the infected lungs. Sequence analysis indicated 77.4% (116) of total
studied VAFs are soluble proteins, and 22.7% (34) are transmembrane proteins. Motifs
involved in regulation and signaling such as protein kinases and transcription factors are
highly enriched in Cryptococcus VAFs. Altogether, this study represents a pioneering
effort in analysis of the virulence composite network of C. neoformans using a systems
biology approach.
Keywords: systems biology and network biology, Cryptococcus neoformans, bioinformatics, host–pathogen
interaction, curation, data collection, mouse models, virulence
INTRODUCTION
Cryptococcus neoformans, a basidiomycetous pathogenic yeast, is a leading cause of fatal mycosis
in AIDS patients (Chuck and Sande, 1989) and a major cause of fungal meningoencephalitis and
central nervous system (CNS)-related mortality around the world (Jarvis and Harrison, 2007).
Most infections with C. neoformans begin in the lungs and later disseminate systemically to other
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organs, most critically, the CNS (Tripathi et al., 2012).
C. neoformans is also an opportunistic pathogen in organ
transplant recipients and patients with hematological
malignancies (Pappas et al., 2001). Although C. neoformans
infections are mostly a manifestation of immune deficiency, up
to 25% of cases reported in the USA represent patients without
recognizable immunodeficiencies (Baddley et al., 2008), and
similar cases are reported in other parts of the world (Hofman
et al., 2004; Zahra et al., 2004; Chen et al., 2008).
Cryptococcus neoformans is broadly distributed worldwide,
is most frequently isolated from cryptococcosis patients with
HIV/AIDS, and can be classified as serotype A, D, or their
rare hybrid, serotype AD (Kwon-Chung and Bennett, 1992;
Mitchell and Perfect, 1995). Cryptococcal strains display different
levels of virulence, ranging from extremely virulent strains that
can infect non-immunocompromised individuals to completely
avirulent. These levels of virulence are associated with differential
expression levels of virulence-associated genes, of which most
have been identified and studied by functional genetic analysis
of a mutant or using a large-scale mutant screening.
Virulence associated factors (VAFs) are an important class of
gene products that help pathogens to survive within the host
through adaption to specific environmental conditions found in
different organs/tissues and through evasion of or interference
with certain host-defense mechanisms. For example, some VAFs
facilitate intracellular survival of C. neoformans in macrophages
(Casadevall and Pirofski, 2009; Lee et al., 2010; Davis et al., 2015)
while others induce pathology-related stress-response pathways
in both Cryptococcus and the host (Fan et al., 2005; Coelho
et al., 2015). VAFs allow for establishing infection, contribute to
pathogenesis and thereby promote the disease state within hosts.
Thus far, many signaling pathways involved in regulating
differentiation and pathogenicity of C. neoformans have been
identified, for example, cAMP-PKA pathway, three MAP kinase
pathways involving Cpk1, Hog1, and Mpk1, the Ras pathway and
the calcium-calcineurin pathway (Kozubowski et al., 2009). These
pathways contain numerous different VAFs. The genes encoding
these VAFs were tested by various laboratories to establish their
possible roles in lung and/or brain virulence using in vivo animal
models (Alspaugh et al., 1998; Olszewski et al., 2010) or in vitro
assays using immune cell cultures, predominantly macrophage
cell lines (Rohatgi and Pirofski, 2015; Shen and Liu, 2015). Genes
that affect virulence in these models are considered classical
VAFs. Some of the “classical” VAFs are predicted to work on
the outside of the cells inducing host-cell damage (Qiu et al.,
2013), but in a broader view many VAFs work by improving
fitness of the microbe, allowing it to survive in the environment
within the host that is different from the external environment
in terms of nutrients availability, O2 and CO2 concentrations,
or the presence of host-derived anti-microbial factors (Mori,
1999).
Bioinformatics approaches have been used to increase the
understanding of biological processes and development of new
algorithms and statistical measures that assess relationships
among members of large data sets. The rapid development
of in silico analytical tools allows for such analysis. For
instance, analysis and interpretation of nucleotide and amino
acid sequences, protein domains, and protein structures enables
us to create databases focusing on various levels of virulence
of microbes (Xiang et al., 2007). Several recent studies used
bioinformatics to identify genes responsible for fitness, genes
encoding virulence traits, metabolic pathways and finding target
molecules for potential vaccines against pathogenic microbes
such as Staphylococcus aureus (Valentino et al., 2014; Delfani
et al., 2015). However, although the virulence genes of C.
neoformans and their amino acid sequences are present in various
databases, we are far from a comprehensive understanding of
their interactions.
Such a comprehensive analysis can be conducted using
STRING. STRING database (Search Tool for the retrieval of
interacting Genes) is a protein–protein interaction database
analysis program generating a network of interactions from a
variety of sources, including different interaction databases, text
mining, genetic interactions, and shared pathway interactions
(Szklarczyk et al., 2015). In addition to finding possible
interactions through STRING analysis, a motif analysis can
be conducted to identify all motifs in each VAF and motifs
which are more commonly shared by several different VAFs.
Finally, membrane localization/distribution of virulence
associated genes may affect their function in pathogenicity. To
determine the membrane distribution of different VAFs we used
TMHMM software analysis. TMHMM utilizes a hidden Markov
model for predicting transmembrane topology and identifying
transmembrane proteins from soluble proteins (Krogh et al.,
2001).
A previous study by Kim et al. (2015) has focused on
protein–protein interactions of cryptococcal VAFs, establishing
a method of predicting proteins associated with pathogenicity
traits. However, STRING offers several features not present
in CryptoNet (Kim et al., 2015), including the possibility to
highlight functional domains, KEGG pathways, and molecular
functions. We have used these features to analyze a majority of
the known VAFs of C. neoformans for the first time in this study,
in an attempt to learn something greater than the sum of the
component genes.
A systemic analysis was performed to identify transmembrane
VAFs with a special focus on those causing infections to the lungs
and the brain. A motif analysis was conducted to identify all
motifs in each VAF and motifs shared by different VAFs. Our
application of these three methods of sequence-based prediction
identified specific patterns in different strains of Cryptococcus
VAFs; and apart from already known pathways, our study
identified virulence function of a new strain-specific gene, SHO1,
likely to be involved in the Hog1 mitogen-activated protein
kinase (MAPK) signaling pathway.
MATERIALS AND METHODS
Data Annotation of C. neoformans VAFs
We manually collected information on 150 virulence related
factors from peer-reviewed publications on PubMed Literature
which have been confirmed in a mammalian model of
infection (Figure 1). For each VAF, we found and recorded
Frontiers in Microbiology | www.frontiersin.org 2 October 2016 | Volume 7 | Article 1652
fmicb-07-01652 October 25, 2016 Time: 14:33 # 3
Malachowski et al. Systemic Virulence Network Analysis of C. neoformans
FIGURE 1 | Systemic workflow of the annotation of Cryptococcus
neoformans virulence associated factors (VAFs). To generate a list of
VAFs and their target organs the entire literature regarding C. neoformans was
searched for virulence studies. For every VAF found, the PMID of the
corresponding peer-reviewed article was recorded, and organ specificity was
deduced from the data. Gene information was then identified from the Broad
Institute’s C. neoformans database and/or the NCBI Gene website, and the
protein sequence was extracted for further analyses.
PMID(s)1 corresponding to a peer-reviewed article(s) that
provided evidence for asserting a Cryptococcus protein as a VAF
(Supplementary Figure S1). For each VAF, gene information was
identified in the Broad Institute C. neoformans databases2 and/or
the NCBI Gene website3, and its protein sequence recorded for
further analyses.
STRING Analysis
To predict interaction networks between VAFs, protein
sequences of VAFs were put into the STRING database4. In
the STRING database, the Cryptococcus organism was selected.
In the current study, those VAFs related to brain and lung
infections were used to generate interaction networks for
C. neoformans B-3501. For generating the figures a confidence
cutoff of 0.4 was used. The resulting network view, under
evidence view, was downloaded for the figure. The database
view contains other views of predicted functional partners, for
example, neighborhood and fusion of these VAFs. To identify
different VAFs involved in MAPK pathways of the pathogenic
Cryptococcus species, the enrichment function was used, which
contains various pathways found on the Kyoto Encyclopedia of
Genes and Genomes.
Transmembrane Analysis
To determine transmembrane probability for each VAF,






2.05) Library in the FASTA format and analyzed using
standard settings. To further determine if there would
be a difference in predicted membrane location among
factors associated with lung vs. brain invasiveness, a
separate TMHMM analysis was performed for four groups
of VAFs: lung alone, brain alone, factors involved in
both brain and lung, and other factors not yet linked
to lung or brain invasion. Furthermore, the annotated
genome was downloaded from the Broad Institute’s
Cryptococcus database and input into STRING-db.
The output file was then analyzed using a Python
script to log total number of transmembrane proteins
and the number of transmembrane helices in each
protein.
Motif Analysis
To identify common motifs from the VAFs, protein sequences
were queried against http://www.genome.jp/tools/motif/MOTIF.
html Library using Pfam (determining positions and description
for each VAF) as shown in Figure 1. Default genome.jp
settings were used for this, with an E-value cutoff score
of 1.0.
Construction of the sho11::SHO1-FLAG
Complemented Strain
We used C. neoformans var. grubii wild-type (H99 strain)
and the sho11 mutant strains (YSB1719) (Kim et al., 2015).
The sho11::SHO1 complemented strain was constructed as
follows. The terminator region of Sho1 was amplified via
PCR by using B4796 and B4797 containing NotI, SacII
restriction sites, respectively, and cloned into a plasmid pTOP-
V2 (Enzynomics). The promoter and ORF region of Sho1 were
amplified via PCR by using B4794 and B4795 including SalI,
NotI restriction sites, respectively, and cloned into a plasmid
pTOP-V2 (Enzynomics). The B4795, containing FLAG sequence
(5′-CTTATCGTCGTCATCCTTGTAATC-3′). After sequencing,
first the NotI and SacII digested SHO1T was subcloned
into a plasmid pJAF12 containing NEO (nourseothricin)
resistance marker. Second, the SalI and NotI digested insert
was subcloned into the SalI and NotI digested pJAF12-
SHO1T to produce a plasmid pJAF12-Sho1-FLAG. The HindIII-
digested linearized pJAF12-SHO1-FLAG was transformed into
the sho11 mutant (YSB1719) and targeted re-integration of
the SHO1-FLAG gene into its native locus was confirmed by
diagnostic PCR. Functionality of the SHO1-FLAG fusion gene
in the new strain (YSB2141) was confirmed by phenotypic
analysis.
Mice
C57Bl/6 (Jackson Labs, Sacramento, CA, USA) were housed
at the Veterans Affairs Ann Arbor animal care facility, and
were used at around 7–9 weeks of age. At the time of
data collection, mice were humanely euthanized by CO2
inhalation. All experiments were approved by the University
5http://www.cbs.dtu.dk/services/TMHMM/
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Committee on the Use and Care of Animals and the




Mice were anesthetized via intraperitoneal injection of
ketamine/xylazine (100/6.8 mg/kg body weight). The trachea was
exposed by making a small incision on the throat and moving
aside underlying salivary glands and cutting away muscle around
the trachea. 104 cells of C. neoformans were inoculated into the
lungs by injecting 30 µL of infection mix (see section above) via
30 gauge needle. After inoculation the salivary gland was moved
back into place and the incision was closed using a cyanoacrylate
adhesive.
Cytokine Assays
Dissected lungs were homogenized in 2 ml of sterile water
with protease inhibitor and homogenates spun at 10000 RPM
for 10 min to collect supernatants that were stored frozen at
−80◦C until cytokines were analyzed. Quantification of levels was
performed using LEGENDplex cytometric bead array (CBA) and
analyzed as described previously (Xu et al., 2016). Lung associated
lymph nodes were dissected and processed, as described by Xu
et al. (2016). Total RNA from node cells was isolated, cDNA
converted and qPCR analysis performed with data normalized to
18S mRNA, as described by Xu et al. (2016).
CFU Assay
Lung homogenates were serially diluted in sterile water. Series
of 10-fold dilutions of the samples were plated on Sabouraud
dextrose agar plates in duplicates in 10-µl aliquots and incubated
at room temperature.C. neoformans colonies were counted 2 days
later, and the number of CFUs was calculated on a per whole lung
basis.
RESULTS
Identification of 150 of C. neoformans
Virulence Genes through Literature
Annotation
Through manual literature annotation, we identified reports on
150 C. neoformans genes which have an effect as established
through in vivo mammalian infection models. This group is
defined by experimental evidence of attenuation of virulence
in a mouse model. For each gene on our list, the following
information was annotated: (1) paper PMID; (2) protein
sequence; (3) gene symbol; (4) protein sequence; and (5) for
confirmed VAF’s effect on infected organ burden in various
articles.
The 150 C. neoformans VAFs identified in this study were
all found in STRING db10 from the total identified genes of
C. neoformans. The network is composed of the interactions
between 150 VAFs that had an impact on the survival of infected
mice. Of these VAFs, 8 had documented effects in promoting
FIGURE 2 | Classification of VAFs according to target organ. VAFs were
categorized according to the organ associated with their virulence based on
fungal burden assays. Of a total 150 VAFs, 28 were lung-specific, 8 were
brain-specific, and 31 were associated with both lung and brain virulence. No
data is available on organ specificity of 83 of the VAFs.
brain infection, 28 were related to lung infection, 31 genes had
dual effects for fungal invasiveness in both organs, and 83 affected
survival with target organ partially or completely unknown
(Figure 2). In some instances, an assay for brain-virulence was
conducted without attention to cryptococcal level or pathology
in the lungs, providing evidence for brain virulence but without
elucidating the role of the gene in lung infection.
STRING Protein–Protein Analysis of
Virulence Genes of Different Strains of
Cryptococcus
While CryptoNet has already been used to predict protein–
protein interactions in C. neoformans virulence genes, STRING
offers several additional features. STRING is more liberal with
assigning interactions, when compared to CryptoNet, because
it uses data from homologous protein interactions in other
organisms. A homology comparison feature is incorporated
into STRING, which makes it easier to determine the function
of un-identified C. neoformans genes. In addition to these
features which we used in this study, STRING also has other
useful features, including a feature that allows for homology
comparisons in a phylogenetic context, and protein family
analysis.
Our STRING analysis of C. neoformans B-3501 strain
generated networks for 150 VAFs associated with lung and brain
virulence. These networks include 410 interactions while 81
interactions could be expected if the collection of genes were
randomly chosen among C. neoformans genes (Figure 3). This
indicates that VAFs act in orchestration.
The nodes on Figures 3 can be loosely classified into two
groups – one group defined by green text-mining interactions
and another group of nodes connected by interactions of all
colors. The area that is defined by text-mining interactions is
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FIGURE 3 | STRING network of VAFs of C. neoformans. Following annotation of 150 cryptococcal genes and establishing organ specificity for each a network
was generated using STRING-db. We also included a predicted VAF, color coded in orange, to illustrate the predictive ability of STRING. The figure is color coded to
indicate organ specificity of the established virulence factor and the interaction ‘strings’ are also color coded to express by what means interaction was determined,
as shown in the legend. By matching the STRING ID # from the outputted image to our collection of VAFs we superimposed the organ specificities and the gene
symbols of the corresponding genes. This allows any cryptologist to get an immediate idea of where a gene of interest lies relative to all other cryptococcal virulence
genes within the context of informatics.
primarily composed of proteins involved in metabolism. The
area which is densely filled with multi-colored interactions
is composed primarily of transcription factors and kinases.
Additionally there are many disconnected nodes, which may
be loosely regulated constitutively expressed genes or genes
whose interacting partners have not been discovered yet in
C. neoformans, or proteins whose homologs have not been
detected in other species by STRING.
Our STRING analysis of C. neoformans VAFs suggests that
there are still many virulence factors to be discovered, and
that not all protein interactions have been elucidated. One
of the disconnected nodes in the STRING analysis, Cuf1, is
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a copper dependent transcription factor (Waterman et al.,
2007). It is expected that functioning as a transcription
factor, Cuf1 regulates transcription of genes including
some genes that are involved in mediating pathogenicity.
Therefore analysis of genes interacting with CUF1 may help
to identify factors that have not been yet recognized as
VAFs.
Alternatively, it could mean that STRING has not yet
effectively incorporated all possible protein–protein interactions
from the literature. For instance, the CAP genes, which are
important for synthesis of the Glucuronoxylomannan (GXM)
capsule, do not yet have any functional interacting partners in
STRING. It has been shown, however, that capsule expression
depends on high CO2 and low-iron conditions (O’Meara and
Alspaugh, 2012). This would indicate that the CAP genes are
interacting partners with CO2 response and iron regulation genes
cac1 and cir1, or some intermediate gene. It appears that these
interactions were missed by the STRING algorithm when it was
mining its sources.
In addition, using the analysis functions of STRING
allows us to highlight the importance of kinases and the
galactoxylomannan (GalXM) capsule components. The
GXM/GalXM capsule is a defining feature of C. neoformans
infection and its prominence is highlighted using STRING.
The expression of the capsule is regulated by several pathways,
discussed above and below, which incorporate numerous
kinases. The CAP genes are identified as mannosyl-transferases,
crucial for creating cross-links of GXM. The GDP-mannose
transporters are primarily important for export and import of the
polysaccharide capsule (Cottrell et al., 2007). Finally, four (Man1,
Uxs1, Ugd1, and Uge1) of the highlighted sugar metabolism
proteins are involved in synthesizing the saccharide components
of the capsule.
Additional information about each protein from our database
cannot be described in detail here, but can be gained by
interactive viewing of our STRING network at6 when our
database (Supplementary Table S1) is imported.
Analysis of VAFs in the MAPK Pathway
using STRING
Using STRING analysis we are able to illustrate a key kinase
pathway that is central to the C. neoformans virulence network
(Figure 4). Hog1 (located in the center of the interaction
chart) is a MAP kinase involved in a signal transduction
pathway that is activated by changes in the osmolarity in the
extracellular environment (Bahn et al., 2005). Hog1 controls
osmotic regulation of transcription of target genes. Hog1 is also
involved in response to UV radiation and mediates sensitivity
to fludioxonil. Hog1 has several strong predicted functional
interactions with: Ste7 (a MAP kinase modulating capsule
formation; Feretzaki et al., 2014), Sch9 (a protein kinase Sch9
modulating cell wall formation; Wang et al., 2004), Gpa1
(a G-protein alpha subunit homolog required for melanin
synthesis, capsule formation and other functions) (Alspaugh
et al., 1997; O’Meara et al., 2010a), and Ras1 (Ras superfamily
6http://string-db.org
GTPase that controls thermotolerance) (Waugh et al., 2002;
Ballou et al., 2013). The most commonly reported biological
functions associated with these proteins are linked to regulation
of C. neoformans pathogenicity, although they appear to regulate
many other aspects of fungal life cycle.
Analysis of total VAFs using Kyoto Encyclopedia of Genes
and Genomics (KEGG) tools in STRING-db indicates that
the MAPK pathway is the most prominent among virulence
factors. Eight VAFs constitute the MAPK signaling pathway
with (p = 8.6 e−4). The proteins are, Hog1, Ste12alphap,
MPK1, Pbs2, Pak1, Pck1, CDC42, and CDC24. The KEGG
is a collection of databases dealing with genomes, biological
pathways, diseases, drugs, and chemical substances, and has
been incorporated into the analysis function of STRING
(Kanehisa and Goto, 2000). KEGG has been widely utilized for
bioinformatics research and education, including data analysis
in genomics, metagenomics, metabolomics, and other -omics
studies, modeling and simulation in systems biology, and
translational research in drug development (Kanehisa et al.,
2010).
In order to more closely investigate this interaction within
MAPK gene network the eight regulators of the MAPK pathway
were inserted into STRING-database (Figure 5A). The top 20
predicted interacting partners include several genes that are
confirmed virulence factors, and many genes which have not yet
been investigated in the context of virulence. Among the four
functional partners in this group that have already been tested,
three are confirmed to be VAFs in vivo at the time of publishing.
Most have not yet been named or studied in C. neoformans,
however. Of the predicted VAFs that have not been tested in vivo
for virulence (Figure 5A) only three have been knocked out
in: RHO, STE20, and SHO1. However, RHO has three close
homologs, and thus determination of its role in pathogenesis will
require extensive studies with many combinations of knockouts.
On the other hand, SHO1 is a gene already known to be a
protein upstream of the MAPK pathway in another pathogenic
fungus Candida albicans, where it serves as cell membrane-
bound receptor protein sensing external osmolality (Biswas et al.,
2007). STE20 is also a good candidate for study, however, it
is down-stream from SHO1 in the HOG pathway (Figure 5B).
Considering all these factors, SHO1 was selected as the best gene
target for verification of virulence in C. neoformans infection
model.
Role of Sho1 in Cryptococcus
neoformans Pathology
Initial studies lead to the conclusion that Sho1 was absent
in C. neoformans. Analysis using STRING and using the
KEGG indicated that Sho1 is present in serotype A strain
H99 and the serotype D strain B-3501 (Figure 5B), but not
present in the serotype D strain JEC21. We suspect that this
was the reason why a Sho1 homolog has not been detected
in C. neoformans until 2015, when it was characterized in
H99 as potential factor in virulence pathways by another
bioinformatics study. Kim et al. (2015) conducted an informatics-
based genome-wide study to identify novel genes for virulence
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FIGURE 4 | KEGG analysis of STRING network of C. neoformans. Our study underlines the importance of the mitogen-activated protein kinase (MAPK)
pathway in the virulence network of C. neoformans. STRING analysis also shows enrichment of galactoxylomannan synthesis and transport, supporting previous
findings regarding the importance of this capsule saccharide. The central role of kinases in the C. neoformans virulence network is also underlined, as is expected
from an opportunistic pathogen that requires rapid upregulation of virulence factors upon entry into the host.
and adaptation to chemical stresses, pinpointing Sho1 among
other VAF candidates. Their study, using A/J mice, has not
shown significant effect of Sho1 on the survival rate of
infected mice. Due to the prominence of this gene in, and
in relation to other genes upstream of, the important HOG
pathway, we decided to conduct a study of fungal burdens
in an experimental mouse model of cryptococcosis to possibly
determine Sho1 role as a factor associated with fungal growth in
the lungs.
A common mechanism by which cryptococcal virulence
factors confer better survival of the pathogen in the host is
through interference with either innate or adaptive host immune
response or both (Olszewski et al., 2010). We analyzed fungal
burdens in the infected lungs of C57BL/6 mice at time points
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FIGURE 5 | Network analysis of MAPK pathway suggests involvement of Sho1 in virulence. In order to test STRING as a predictor of new virulence factors,
all identified VAFs from the MAPK pathway were inserted into STRING to select the top 20 interactors (A). The identity of proteins marked with an asterisk (∗) could
only be obtained from homologous proteins. One of the top predicted partners is Sho1. The role of Sho1 in C. neoformans MAPK pathway has not been
investigated until very recently, perhaps because it is absent in the laboratory strain JEC21. However, we have confirmed its presence in the C. neoformans B-3501
genome by STRING analysis and also the KEGG (B).
consistent with the immediate adaptation to the host tissue
conditions (day 3), interference with the innate (day 7), and
with the adaptive phase of the immune response (day 14). Lungs
were collected and homogenized to assay for fungal burdens.
Cytokine response was also assessed for possible effects of Sho1
on Th1/ Th2 bias, which is an important index of protective vs.
non-protective response used in C. neoformans virulence studies
(Osterholzer et al., 2009; Zhang et al., 2010; He et al., 2012; Qiu J.
et al., 2012).
This fungal burden assay indicated no significant difference
between wild type strain and the sho11 and sho11::SHO1
mutants on day 3, but significantly lower fungal burdens in the
sho11-infected lungs were detected on days 7 and 14 compared
to wild type and sho11::SHO1 infections (Figure 6A). These
results indicate that SHO1 expression is not required for the
immediate adaptation of C. neoformans to lung environment
but it supports optimal growth rate of the pathogen at time
points consistent with the innate fungal control (Eastman et al.,
2015) and the development of the polarized adaptive immunity
(Osterholzer et al., 2009; Eastman et al., 2015), suggesting that
SHO1 may have a role in promoting immunomodulatory effects
of C. neoformans.
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FIGURE 6 | Sho1 enhances pulmonary virulence of C. neoformans by
skewing lung cytokine balance toward non-protective Th2 profile.
C57Bl/6 mice infected intratracheally with 104 cells of wild-type strain H99
C. neoformans, SHO1-deleted mutant sho11, or complement strain
sho11::SHO1 and analyzed at selected time points. Lungs were
homogenized, serially diluted and plated for fungal burden evaluation (A).
Cytokine levels in supernatant from undiluted homogenates were evaluated by
CBA (B,C). Significant differences between fungal burdens in the lungs
infected with sho11 vs. those infected with SHO1-sufficient strains were
found at days 7 and 14, but not day 3 post-infection, indicating that SHO1 is
not required for initial survival of organism in the host, but is important for
pulmonary virulence (A). Furthermore, non-protective Th2 cytokines IL-4, IL-5,
and IL-13 were highly abundant in the lungs infected with SHO1-sufficent
strains and only minimally induced in those infected with sho11 (B). The
overall Th1/Th2 cytokine balance was expressed as Th1/Th2 index ratio at
day 14. Ratio of summarized Th1 cytokines (IFNγ and TNFα) to Th2 cytokines
(IL-4, IL-5, and IL-13) shows that cryptococcal SHO1 deletion resulted in a
shift toward protective Th1 and away from non-protective Th2 cytokines.
Parametric data were analyzed by ANOVA with Dunnet’s post-test while ratios
were analyzed by Kruskal–Wallis non-parametric test. N = 4 or above mice
per time point per group ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
In support of this, we observed greatly enhanced levels of
non-protective Th2 cytokines (IL-4, IL-5, and IL-13) in lungs
infected with SHO1-sufficient strains compared to lungs infected
with sho11 at day 14 (Figure 6B). Since the much higher
fungal burdens in H99 and sho11::SHO1 at day 14 likely
contributed to overall higher cytokine levels in these groups,
we analyzed Th1 (IFNγ and TNFα) vs. Th2 (IL-4, IL-5, and
IL-13) cytokine ratios generating combined Th1/Th2 cytokine
index ratio (Figure 6C). This index reflects overall balance of
these cytokines in each infected animal, rather than individual
cytokine levels and thus is much less affected by the fungal
load. This analysis revealed that the Th1/Th2 cytokine balance
was consistently and significantly more skewed toward Th1
in sho11-infected lungs and more toward Th2 in the lungs
infected with SHO1-sufficient strains (Figure 6C), suggesting that
cryptococcal SHO1-expression contributes to the development of
non-protective Th2 bias.
To further support this we assessed gene expression in
lung associated nodes on day 7, a time point consistent with
early priming of the adaptive immune response in the nodes
(Xu et al., 2016). Accordingly, we have found that SHO1-
deletion enhanced early expression of protective cytokines IFNγ
and IL-17 (Supplementary Figure S1) and resulted in strong
trends in upregulation of transcription factors Tbet and RorγT,
responsible for the development of protective Th1 and Th17 cells.
Thus, cryptococcal SHO1 expression clearly promoted expansion
of C. neoformans in the infected lungs and contributed to




Both soluble and transmembrane proteins should be important
for the pathogenicity of C. neoformans; however, these proteins
have not been systematically studied as a group. Multiple in vivo
studies confirm that intracellular proteins involved in metabolism
and catabolism are vital to C. neoformans proliferation in the
lungs and dissemination to the brain (Olszewski et al., 2004; Qiu
Y. et al., 2012). On the other hand, the outer capsule is considered
one of the defining pathogenicity factors of C. neoformans.
Acapsular strains of C. neoformans are generally categorized as
non-pathogenic (Okabayashi et al., 2005; O’Meara and Alspaugh,
2012). Also, many studies indicate membrane composition in
C. neoformans determines various aspects of pathogenicity, for
instance ability to cross the blood brain barrier, and organization
of VAFs on the fungal membrane (Siafakas et al., 2006; Singh
et al., 2012; Stie and Fox, 2012). Here we classify our collection
of VAFs into soluble and transmembrane VAFs using TMHMM.
TMHMM v 2.0 utilizes a hidden Markov model to determine
transmembrane domains on proteins, with the ability to
distinguish cytoplasmic and outer domains (Krogh et al., 2001),
and is currently one of the most accurate membrane protein
topology prediction methods. To validate the accuracy of
TMHMM, we tested the transporters and transcription factor
VAFs of C. neoformans. Because transporters are inherently
membrane-associated and transcription factors localize in the
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FIGURE 7 | Transmembrane analysis of known C. neoformans virulence factors compared to all annotated C. neoformans genes. Protein sequences
were input into TMHMM Server V 2.0, and the resulting plot was interpreted to determine membrane specificity (transmembrane or soluble) of the virulence factor.
Transcription factor and transporters are included as a negative and positive control, respectively (A). To look at the composition of transmembrane proteins we also
analyzed the number of transmembrane helices of each transmembrane protein. The maximum number of transmembrane helices was 20, but only proteins with
less than 15 transmembrane helices were frequent. This study indicates that compared to the genome, VAFs are enriched in proteins with six transmembrane
helices but otherwise have a similar distribution of the number of transmembrane helices (B). Data were analyzed using Pearson’s chi-square test. ∗p < 0.05.
nucleus, these are positive and negative controls, respectively
(Figure 7A).
Overall, the majority of VAFs showed characteristics of soluble
proteins regardless of their association with target organs. Using
the TMHMM method, we found that of the 150 known organ
specific VAFs of C. neoformans B-3501 77.3% (116) are soluble
VAFs and 22.7% (34) are transmembrane (Figure 7A). Among
CNS and lung-virulence-related VAFs (31): 81% (26) were soluble
and 19% (9) were membrane associated. Among VAFs related
to pulmonary infection (28): 68% (19) were soluble proteins,
32% (9) are transmembrane proteins. The VAFs which promote
infection in brain (8): consisted of 63% (5) soluble proteins and
37% (3) transmembrane proteins. Finally, among VAFs which
have incompletely known target organ (83): 76% (63) were non-
membrane proteins and 24% (20) were transmembrane proteins.
Additionally, we conducted a TMHMM study of all annotated
C. neoformans genes to elucidate whether VAFs were enriched
in transmembrane domains. Of a total 6962 genes, 1354 (19.4%)
contain transmembrane domains, compared to 22.6% in our VAF
database (Figure 7B). This suggests that both transmembrane
and soluble proteins are equally important in the pathogenicity
of C. neoformans.
In order to define the functionality of transmembrane VAFs
we recorded their functions (Table 1). The largest group is ion
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TABLE 1 | Classification of transmembrane virulence associated factors
(VAFs) of Cryptococcus neoformans.
Functional group Number of
proteins in group
List of VAF symbols
Capsule synthesis
and maintenance
7 Cap10, Cap64, Cas1,
Cxt1, Kre6, Ktr3, Ugt1
Miscellaneous 4 Afr1, Ena1, Liv5, Vtc4
Calcium
homeostasis
3 Clc1, Pmc1, Vcx1
Cell wall 3 Chs3, Cps1, Pmt
Copper
homeostasis
3 Cmt1, Ctr4, Vph1
Glycosylation/palmitoylation 3 Gmt1, Gmt2, Pfa4
Sphingolipid
metabolism
3 Gcs1, Ipc1, Isc1
Sterol metabolism 3 Scp1, Smt1, Stp1
Iron homeostasis 2 Cfo1, Fre3
Nutrient transport 2 Hxs1, Itr1a
sensors and transporters, which play a key role in regulating
ion homeostasis and expression of virulence genes within the
host (Silva et al., 2011; Jung et al., 2012). Proteins related
to mannose and xylose transport and crosslinking are also
numerous and these are the proteins required for construction
of the immune-modulating capsule of C. neoformans. Another
important group of transmembrane VAFs are involved in lipid
metabolism, particularly sterols and sphingolipids, which are an
important multi-functional membrane component of this fungal
pathogen (Siafakas et al., 2006).
To further analyze transmembrane VAFs as a group the
number of transmembrane helices present in each protein was
determined, in the genome and on our list of VAFs. Although our
study indicates that proteins with six transmembrane domains
are more frequent among VAFs than the general gene pool
(Figure 7B), the proteins in this group function independently of
one another and do not possess functional interacting partners in
STRING, so we are assuming this is only a coincidence. Although
not significant at the statistical level, no VAFs with seven or eight
transmembrane domains have been found. In conclusion, the
proportion of transmembrane helices in VAFs is similar to that
in total genomic proteins.
Motif Analysis of Cryptococcus VAFs
To further expand our analysis and sort the VAFs based on their
expression of functional domains, all 150 organ-specific VAFs
were queried against the Motif Search Library (Kanehisa, 1997).
Table 2 lists the top common motifs in VAFs of Cryptococcus
resulting from this analysis.
The protein kinase (PK) family motif (PF00069) is present
in 14 VAFs and is the most common motif among all VAFs.
Since C. neoformans is an opportunistic pathogen, it requires
efficient upregulation of pathogenicity genes once it enters the
stressful host microenvironment, a role partially filled by kinase
phosphorylation. Many VAFs from this pathway have been
identified, for example, Tyrosine PK, Kinase-like proteins, APH
(Phosphotransferase enzyme family) present in MAP kinase
pathway, and cAMP-PKA pathway.
Concurrent with the high frequency of kinases, DNA binding
proteins are also very frequent among VAFs. Two distinct groups
of zinc fingers are found in the VAFs of C. neoformans: GATA
and the C2H2, H2C2_2, H2C2_4 proteins. Most of these DNA
binding proteins are transcription factors, which is consistent
with importance of kinases as regulators in virulence. Efficient
upregulation of pathogenicity factors and stress response genes is
key to C. neoformans success in evading host immune responses.
This might suggest that disrupting the fine-tuned regulatory
process in C. neoformans may be a viable alternative to antibiotic
treatments.
Finally, we analyzed a less frequent but equally interesting set
of genes linked by one motif: the FoxP coiled coil domain, found
in three proteins of C. neoformans (Znf2, Zap103, and Rim101),
all of which decrease virulence in a mouse model of infection.
Although the FoxP domain in mammalian leukocytes facilitates
dimerization of FoxP transcription factors and commitment to
a T regulatory lineage, Znf2 and Rim101 have very disparate
roles and different impacts on cell morphology (Lin et al., 2010;
O’Meara et al., 2010b), so it seems unlikely that they dimerize.
Zap103 was only recently shown to have impact on virulence in
TABLE 2 | Most frequent Motifs among C. neoformans VAFs.
Motifs symbols Description List of VAF symbols
Pkinase PF00069, Protein kinase domain 14: Cck1, Gsk3, Hog1, Ire1, Kin1, Mpk1, Pak1, Pbs2, Pck1, Pka1, Sch9, Snf1,
Ste20a, Ypk1
Pkinase_Tyr PF07714, Protein tyrosine kinase 14: Cck1, Gsk3, Hog1, Ire1, Kin1, Mpk1, Pak1, Pbs2, Pck1, Pka1, Sch9, Snf1,
Ste20a, Ypk1
Kinase-like PF14531, Kinase-like 11: Gsk3, Hog1, Kin1, Pak1, Pbs2, Pck1, Pka1, Sch9, Snf1, Ste20a, Ypk1
APH PF01636, Phosphotransferase enzyme family 10: Gpa1, Gsk3, Ire1, Kin1, Mpk1, Pak1, Pbs2, Pka1, Sch9, Ste20a
Kdo PF06293, Lipopolysaccharide kinase (Kdo/WaaP) family 10: Gsk3, Pak1, Sch9, Snf1, Ste20a, Ypk1, Hog1, Ipc1, Kin1, Mpk1
GATA PF00320, GATA zinc finger called zinc-containing domains 5: Bwc2, Cir1, Gat1, Gat201, Gat204
zf-C2H2 PF00096, Zinc finger, C2H2 type 5: Nrg1, Rim101, Ste12alphap, Zap103, Znf2
zf-H2C2_2 PF13465, Zinc-finger double domain 5: Nrg1, Rim101, Ste12alphap, Zap103, Znf2
zf-C2H2_4 PF13894, C2H2-type zinc finger 5: Nrg1, Rim101, Ste12alphap, Zap103, Znf2
Motif names were grouped since they shared in the same VAF. A complete table of C. neoformans virulence associated factor (VAF) Motifs, categorized by organ specificity
is available in the supplement. (Underline: lung, bold: brain, bold+underline: both, Non: Unknown target organ)
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a mouse survival screen (Kim et al., 2015); knockout of Zap103
also leads to increased virulence. The immediate question is
whether the FoxP-cc domain is the reason these three proteins
are all negative regulators of virulence, or whether it is just an
unexpected coincidence. Additionally, as an input for STRING-
db, these genes are very effective predictors of other VAFs. Of
the top 20 interactors, 9 have a confirmed direct impact on organ
fungal burden or survival, while 11 have not yet been tested.
CONCLUSION AND DISCUSSION
In this study, we have made the first attempt to collect and analyze
the total VAFs of C. neoformans. All VAFs studied were manually
selected from the literature based solely on experimental evidence
and systematically analyzed using three bioinformatics methods.
We defined comprehensive interactions among these VAFs based
on their reported roles in different pathogenicity pathways, as
well as their involvement in pathogenesis of both lungs and the
CNS infections. These identified VAFs were used to create a
network using the STRING database in order to identify their
relation to other genes. A systematic analysis was performed on
the transmembrane proteins of this list of VAFs, comparing it to
the general gene pool of C. neoformans.
It is an important observation that 77.3% of VAFs are soluble
proteins. However, this percentage may differ according to
target organ, among CNS 62% of VAF were soluble while in
lung infection 68% were soluble. Our genomic TMHMM study
indicated 80.4% of all annotated C. neoformans genes contain
transmembrane domains, but this is not significantly different
from the list of VAFs collected in this study. The TMHMM
study also points to transporters and channels as particularly
important or at least well-represented among pathogenicity
factors. However, while future studies may indicate whether
transmembrane proteins or transporters are in fact particularly
important for cryptococcal tropism to specific mammalian
organs or tissues, at this time no such trend exists.
Our systematic literature study also draws attention to the
significance of a clinically important osmosensor in the high
osmolarity glycerol (HOG) pathway, Sho1. While initial studies
have shown no effect of Sho1 on virulence (Kim et al., 2015),
our new data motivated by the bioinformatics analysis shows
that Sho1 is in fact an important component of pulmonary
virulence in C. neoformans serotype A. No difference in CFU
numbers between sho11 and H99 at day 3 indicating, that
Sho1 is not required for H99 survival in the naive lung
environment; however, its deletion resulted in growth to lower
titers compared to the SHO1-sufficient strains by day 7 and
progressive widening of the gap in fungal burdens between sho11
and SHO1-sufficient strains on day 14, suggesting that Sho1
contributes to immunomodulatory properties of C. neoformans.
Our data support this view, at least with regards to Sho1
contributing to the development of non-protective Th2 bias,
which is known mechanism of cryptococcal virulence (Zhang
et al., 2009; Olszewski et al., 2010). While future studies will be
needed to pinpoint the exact role of Sho1 in pulmonary virulence,
this analysis identified yet unknown role of cryptococcal Sho1
in promoting fungal expansion in the infected lungs and its
contribution to immunomodulatory potential of the cryptococcal
organism.
The absence of Sho1 in the less virulent strain JEC21 may
highlight the genetic reason for the divergence of the role of
the HOG pathway in cryptococcal strains JEC21 and B-3501.
If Sho1 is indeed an upstream member of the HOG pathway in
C. neoformans, like it is in S. cerevisiae, work relating to other
MAPK pathways in C. neoformans may have to be re-analyzed.
Two authors of this paper are currently working to specify the
role of Sho1 in this context.
This study has also identified a number of motifs present
in many VAFs in Cryptococcus by identification of domains
that occur within proteins and therefore give insight into
their function. This provides us a way to search these motifs
(e.g., p-kinase and GATA) for development of new drugs and
vaccines against cryptococcal infection. Identifying essential
specific fungal genes and motifs not present in the host will enable
us to design specific, non-toxic inhibitors and reveals a lot about
the virulence pathways of a pathogen, providing motivation for
further studies using new VAFs that become known in the future.
The prominence of regulatory networks among C. neoformans
genes tested for virulence might suggest that disrupting these
networks can be an effective alternative to existing antifungal
antibiotics.
Regarding future directions, our downloadable database
(Supplementary Data) can be expanded either manually by
adding new virulence factors as new publications become
available in literature, or through introduction of algorithms that
would detect automatically new reports on virulence factors. At
current state of knowledge, manual annotation appears to be
a superior alternative to automated annotation, especially that
we are not aware of an algorithm for determining the target of
study of a scientific publication at the precision level that this
type of analysis requires. While this means our study may not
cover 100% of proven VAFs even at the time of publishing, it still
allows for a systems-level analysis of the majority of confirmed
VAFs. Furthermore, following necessary updates this approach
can be reused to obtain continuously more comprehensive type
of analysis that may result in identification of new virulence
factors and help us to understand their mutual interactions at an
increasingly advanced level. We also believe that future studies
combining analysis of multiple putative novel cryptococcal VAF
genes in experimental infections will be needed to further
demonstrate power of broader usefulness of the in silico analysis
in discovery of new VAFs.
In summary, the results in this report are significant
and novel as such comprehensive analysis to our knowledge
has not been yet reported for C. neoformans. This detailed
analysis of experimentally verified VAFs of various strains
of Cryptococcus provides a powerful way to analyze and
predict specific interactions between different VAFs and can
be continuously expanded as new reports of VAFs become
available. Our analysis, while making the first step in systemic
studies of C. neoformans, constitutes a foundation for future
studies. We anticipate that other researchers will be able
to utilize our database and conduct bioinformatics studies
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of their own expanded with additional new factors. The
usefulness of these systemic studies can be seen immediately, as
is shown by our identification of the SHO1 gene in the mitogen
activated protein kinase pathway of Cryptococcus as a potential
VAF and providing novel evidence that it can play a significant
role in cryptococcal virulence.
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